|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/ Partnership/ Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|David J. Slotwiner (Chair)||Chief, Division of Cardiology, Assistant Professor of Medicine, School of Health Policy & Research, New York Presbyterian Queens/Weill Cornell Medical College||None||None||None||None||None||None|
|Merritt H. Raitt (Vice Chair)||Chief of Cardiology, VA Portland Health Care System, Director, VA National Cardiac Device Surveillance Program||None||None||None||None||None||None|
|Freddy Del-Carpio Munoz||Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science||None||None||None||None||None||None|
|Siva K. Mulpuru||Associate Professor of Medicine, Mayo Clinic College of Medicine and Science||None||None||None||None||None||None|
|Naseer Nasser||Attending Cardiac Electrophysiologist, South Bend Clinic||None||None||None||None||None||None|
|Pamela N. Peterson||Associate Professor, Medicine, University of Colorado School of Medicine, Cardiology||None||None||None||None||None||None|
This table represents the relationships of evidence review committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
CMS reported research payments to Dr. Del-Carpio Munoz in November 2016. Dr. Del-Carpio Munoz personally receives no money from Boehringer Ingelheim as the PI for the GLORIA registry; his hospital receives some reimbursement. Boehringer Ingelheim was deemed not relevant to the ERC report.
ACC indicates American College of Cardiology; AHA, American Heart Association; HRS, Heart Rhythm Society; and VA, Veterans Affairs.